Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$106M |
| 2 |
NXP Semiconductors
NXPI
|
+$93.6M |
| 3 |
Alibaba
BABA
|
+$90M |
| 4 |
ExxonMobil
XOM
|
+$83.7M |
| 5 |
Charter Communications
CHTR
|
+$82.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield
BN
|
+$162M |
| 2 |
B
Barrick Mining
B
|
+$156M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$144M |
| 4 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$65.4M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.13% |
| 2 | Technology | 14.52% |
| 3 | Consumer Staples | 10.68% |
| 4 | Consumer Discretionary | 10.21% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Best Buy
BBY
$17.4B
| $25M | 0.04% |
816,860
+11,200
| +1% | +$352K |
|
452
Albemarle
ALB
$15.5B
| $25M | 0.04% |
314,606
+23,000
| +8% | +$1.69M |
|
|
PDCO
453
DELISTED
Patterson Companies, Inc.
PDCO
| $24.9M | 0.04% |
520,158
+6,700
| +1% | +$309K |
|
454
Capri Holdings
CPRI
$1.75B
| $24.9M | 0.04% |
503,000
+24,800
| +5% | +$1.22M |
|
455
ResMed
RMD
$31.9B
| $24.8M | 0.04% |
392,400
+29,700
| +8% | +$1.75M |
|
|
SRCL
456
DELISTED
Stericycle Inc
SRCL
| $24.8M | 0.04% |
238,200
-151,964
| -39% | -$16.3M |
|
|
HOLX
457
DELISTED
Hologic
HOLX
| $24.8M | 0.04% |
715,924
+91,100
| +15% | +$3.15M |
|
|
WP
458
DELISTED
Worldpay, Inc.
WP
| $24.7M | 0.04% |
435,800
+30,000
| +7% | +$1.62M |
|
459
The Mosaic Company
MOS
$7.46B
| $24.6M | 0.04% |
938,665
+110,900
| +13% | +$2.94M |
|
|
NFX
460
DELISTED
Newfield Exploration
NFX
| $24.5M | 0.04% |
555,500
+230,337
| +71% | +$8.84M |
|
|
TSS
461
DELISTED
Total System Services, Inc.
TSS
| $24.5M | 0.04% |
462,018
+31,900
| +7% | +$1.65M |
|
462
Cameco
CCJ
$42.4B
| $24.5M | 0.04% |
2,239,400
+88,400
| +4% | +$1.05M |
|
|
VER
463
DELISTED
VEREIT, Inc.
VER
| $24.4M | 0.04% |
481,876
+7,660
| +2% | +$361K |
|
464
Jazz Pharmaceuticals
JAZZ
$16.7B
| $24.2M | 0.04% |
171,600
+11,800
| +7% | +$1.74M |
|
465
VeriSign
VRSN
$26.5B
| $23.9M | 0.04% |
276,230
+15,200
| +6% | +$1.31M |
|
466
NiSource
NI
$20B
| $23.8M | 0.04% |
898,900
+356,947
| +66% | +$8.57M |
|
|
Y
467
DELISTED
Alleghany Corp
Y
| $23.7M | 0.04% |
43,200
+2,700
| +7% | +$1.41M |
|
468
Arthur J. Gallagher & Co
AJG
$64.7B
| $23.6M | 0.04% |
496,385
+37,500
| +8% | +$1.74M |
|
469
Workday
WDAY
$45.5B
| $23.4M | 0.04% |
314,000
+23,000
| +8% | +$1.75M |
|
470
Bunge Global
BG
$21.6B
| $23.4M | 0.04% |
395,035
+25,000
| +7% | +$1.53M |
|
471
Harley-Davidson
HOG
$2.72B
| $23.4M | 0.04% |
515,796
+17,400
| +3% | +$801K |
|
472
Idexx Laboratories
IDXX
$46.9B
| $23.3M | 0.04% |
251,100
+97,900
| +64% | +$8.41M |
|
473
Cooper Companies
COO
$14.9B
| $23.3M | 0.04% |
542,800
+37,600
| +7% | +$1.5M |
|
474
Lennar Class A
LEN
$20.6B
| $23.3M | 0.04% |
530,533
+41,917
| +9% | +$1.83M |
|
475
Atmos Energy
ATO
$28.4B
| $23.3M | 0.04% |
286,000
+20,800
| +8% | +$1.54M |
|
Similar funds
Swiss National Bank's Q2 2016 Portfolio in Review
As of Q2 2016, Swiss National Bank held 2,670 positions worth $61.8B, up 13% from $54.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Swiss National Bank deployed $3.47B of net new capital in Q2 2016, opening 59 new positions and adding to 1,417 existing holdings. Its largest new stake was Under Armour Class C: 522,612 shares worth $19M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Kimberly-Clark, an estimated $19.6M trimmed.
- Swiss National Bank's largest Q2 2016 buy was Under Armour Class C: 522,612 shares worth $19M.
- Swiss National Bank added most to Apple in Q2 2016, an estimated $106M increase.
- Swiss National Bank's biggest Q2 2016 reduction was Kimberly-Clark, cutting an estimated $19.6M.
- Swiss National Bank fully exited Brookfield in Q2 2016, selling an estimated $162M.
- Swiss National Bank's ten largest holdings make up 15% of its $61.8B portfolio in Q2 2016.
- Swiss National Bank opened 59 new positions and closed 89 in Q2 2016.
- Swiss National Bank's portfolio value rose 13% quarter-over-quarter to $61.8B.
Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.